Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease

Despite widespread clinical use in the treatment of type 2 diabetes, the impact of sulfonylurea therapy on cardiovascular outcomes remains uncertain. Studies of naturally occurring genetic variation can be used to anticipate the expected clinical consequences of a pharmacological therapy. A common m...

Descripción completa

Detalles Bibliográficos
Autores principales: Emdin, Connor A., Klarin, Derek, Natarajan, Pradeep, Florez, Jose C., Kathiresan, Sekar, Khera, Amit V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Genetics/Genomes/Proteomics/Metabolomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521864/
https://www.ncbi.nlm.nih.gov/pubmed/28411266
http://dx.doi.org/10.2337/db17-0149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521864/
https://www.ncbi.nlm.nih.gov/pubmed/28411266
http://dx.doi.org/10.2337/db17-0149

Ejemplares similares